NCT05882734 2026-02-17Tuvusertib (M1774) in Combination With Cemiplimab in Participants With Non-Squamous NSCLC (DDRiver NSCLC 322)EMD SeronoPhase 1/2 Active not recruiting61 enrolled
NCT05128487 2024-11-25A Study of NDI 1150-101 in Patients With Solid TumorsNimbus TherapeuticsPhase 1/2 Active not recruiting106 enrolled
NCT03678883 2024-11-079-ING-41 in Patients with Advanced CancersActuate Therapeutics Inc.Phase 2 Active not recruiting350 enrolled